Sorrento Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Sorrento Therapeutics, Inc.‘s stocks are currently a part of 214 hedge funds’ portfolios, which represents 41.7% of the total amount of its stocks outstanding. This makes up a total of 128.79M shares of Sorrento Therapeutics, Inc.. Compared to the previous quarter, the number grew by 39.09% or 36.19M shares more. As for the holding position changes, 38.32% (82) of current hedge fund investors increased the number of shares held, 15.42% (33) of current holders sold a part of the shares held, and 17.76% (38) closed the holdings completely. 40 hedge funds are new holders of Sorrento Therapeutics, Inc. stock in Q1 2022, it is 18.69% of total holders.
Hedge funds holding Sorrento Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 45 |
|---|---|
| Q3 2017 | 35 |
| Q4 2017 | 46 |
| Q1 2018 | 71 |
| Q2 2018 | 92 |
| Q3 2018 | 95 |
| Q4 2018 | 73 |
| Q1 2019 | 81 |
| Q2 2019 | 81 |
| Q3 2019 | 81 |
| Q4 2019 | 85 |
| Q1 2020 | 89 |
| Q2 2020 | 178 |
| Q3 2020 | 205 |
| Q4 2020 | 210 |
| Q1 2021 | 219 |
| Q2 2021 | 200 |
| Q3 2021 | 206 |
| Q4 2021 | 218 |
| Q1 2022 | 214 |
Hedge funds changes in Sorrento Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 13 | 17 | 6 | 30 | -21 |
|---|---|---|---|---|---|
| Q3 2017 | 3 | 11 | 14 | 12 | -5 |
| Q4 2017 | 18 | 13 | 9 | 7 | -1 |
| Q1 2018 | 32 | 24 | 10 | 7 | -2 |
| Q2 2018 | 46 | 22 | 13 | 25 | -14 |
| Q3 2018 | 19 | 29 | 23 | 16 | 8 |
| Q4 2018 | 8 | 35 | 16 | 30 | -16 |
| Q1 2019 | 18 | 25 | 22 | 10 | 6 |
| Q2 2019 | 10 | 32 | 16 | 8 | 15 |
| Q3 2019 | 11 | 31 | 18 | 11 | 10 |
| Q4 2019 | 22 | 30 | 19 | 17 | -3 |
| Q1 2020 | 20 | 39 | 15 | 14 | 1 |
| Q2 2020 | 98 | 54 | 19 | 10 | -3 |
| Q3 2020 | 58 | 83 | 40 | 30 | -6 |
| Q4 2020 | 52 | 79 | 41 | 45 | -7 |
| Q1 2021 | 46 | 68 | 65 | 34 | 6 |
| Q2 2021 | 28 | 69 | 52 | 47 | 4 |
| Q3 2021 | 27 | 68 | 51 | 18 | 42 |
| Q4 2021 | 48 | 68 | 58 | 35 | 9 |
| Q1 2022 | 40 | 82 | 33 | 38 | 21 |
Hedge funds changes in Sorrento Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 13,000 | 9,000 |
|---|---|---|
| Q3 2017 | 15,000 | 6,000 |
| Q4 2017 | 103,000 | 25,000 |
| Q1 2018 | 1,043,000 | 1,669,000 |
| Q2 2018 | 3,765,000 | 7,050,000 |
| Q3 2018 | 249,000 | 1,995,000 |
| Q4 2018 | 313,000 | 270,000 |
| Q1 2019 | 2,450,000 | 1,984,000 |
| Q2 2019 | 1,574,000 | 1,152,000 |
| Q3 2019 | 901,000 | 813,000 |
| Q4 2019 | 2,273,000 | 3,450,000 |
| Q1 2020 | 2,278,000 | 1,318,000 |
| Q2 2020 | 46,001,000 | 26,892,000 |
| Q3 2020 | 161,515,000 | 65,332,000 |
| Q4 2020 | 90,290,000 | 47,897,000 |
| Q1 2021 | 75,730,000 | 39,134,000 |
| Q2 2021 | 96,679,000 | 46,918,000 |
| Q3 2021 | 75,180,000 | 38,127,000 |
| Q4 2021 | 48,888,000 | 24,852,000 |
| Q1 2022 | 10,954,000 | 3,762,000 |